OBJECTIVE: Available clinical data raise the possibility that stress-adaptive mechanisms differ by gender. However, this notion has not been rigorously tested in relation to cortisol-mediated negative feedback. MATERIALS/ METHODS: Degree of ACTH inhibition during and recovery from an experimental cortisol clamp was tested in 20 healthy older subjects (age 60±2.2 y). Volunteers received oral placebo or ketoconazole (KTCZ) to inhibit adrenal steroidogenesis along with i.v. infusions of saline or a low vs high physiological dose of cortisol in a prospectively randomized double-blind, placebo-controlled design. ACTH and cortisol concentrations were measured every 10 min during the feedback-clamp phase and thereafter (recovery or escape phase). Corticosteroid-binding globulin (CBG) was measured, and free cortisol concentrations were calculated. RESULTS: Gender did not determine mean ACTH concentrations during the saline or cortisol feedback-clamp phases per se. However, women had markedly impaired ACTH recovery after stopping both low- and high-dose cortisol infusions compared with men (P=0.005, KTCZ/low-dose cortisol arm; and P=0.006, KTCZ/high-dose cortisol arm). Decreased ACTH recovery in women was accompanied by lower total and free cortisol concentrations, pointing to heightened feedback inhibition of hypothalamo-pituitary drive of ACTH secretion as the main mechanism. CONCLUSIONS: In summary, gender or a factor related to gender, such as sex steroids or body composition, determines recovery of ACTH secretion from cortisol-enforced negative feedback. Attenuated ACTH recovery in post-menopausal women may have relevance to sex differences in stress-related adaptations.
RCT Entities:
OBJECTIVE: Available clinical data raise the possibility that stress-adaptive mechanisms differ by gender. However, this notion has not been rigorously tested in relation to cortisol-mediated negative feedback. MATERIALS/ METHODS: Degree of ACTH inhibition during and recovery from an experimental cortisol clamp was tested in 20 healthy older subjects (age 60±2.2 y). Volunteers received oral placebo or ketoconazole (KTCZ) to inhibit adrenal steroidogenesis along with i.v. infusions of saline or a low vs high physiological dose of cortisol in a prospectively randomized double-blind, placebo-controlled design. ACTH and cortisol concentrations were measured every 10 min during the feedback-clamp phase and thereafter (recovery or escape phase). Corticosteroid-binding globulin (CBG) was measured, and free cortisol concentrations were calculated. RESULTS: Gender did not determine mean ACTH concentrations during the saline or cortisol feedback-clamp phases per se. However, women had markedly impaired ACTH recovery after stopping both low- and high-dose cortisol infusions compared with men (P=0.005, KTCZ/low-dose cortisol arm; and P=0.006, KTCZ/high-dose cortisol arm). Decreased ACTH recovery in women was accompanied by lower total and free cortisol concentrations, pointing to heightened feedback inhibition of hypothalamo-pituitary drive of ACTH secretion as the main mechanism. CONCLUSIONS: In summary, gender or a factor related to gender, such as sex steroids or body composition, determines recovery of ACTH secretion from cortisol-enforced negative feedback. Attenuated ACTH recovery in post-menopausal women may have relevance to sex differences in stress-related adaptations.
Authors: J D Veldhuis; A Iranmanesh; D Naftolowitz; N Tatham; F Cassidy; B J Carroll Journal: J Clin Endocrinol Metab Date: 2001-11 Impact factor: 5.958
Authors: W S Evans; M J Sollenberger; R A Booth; A D Rogol; R J Urban; E C Carlsen; M L Johnson; J D Veldhuis Journal: Endocr Rev Date: 1992-02 Impact factor: 19.871
Authors: B M Kudielka; J Hellhammer; D H Hellhammer; O T Wolf; K M Pirke; E Varadi; J Pilz; C Kirschbaum Journal: J Clin Endocrinol Metab Date: 1998-05 Impact factor: 5.958
Authors: C W Wilkinson; E C Petrie; S R Murray; E A Colasurdo; M A Raskind; E R Peskind Journal: J Clin Endocrinol Metab Date: 2001-02 Impact factor: 5.958
Authors: John G Lewis; Christopher J Bagley; Peter A Elder; Anthony W Bachmann; David J Torpy Journal: Clin Chim Acta Date: 2005-09 Impact factor: 3.786
Authors: N A Huizenga; J W Koper; P de Lange; H A Pols; R P Stolk; D E Grobbee; F H de Jong; S W Lamberts Journal: J Clin Endocrinol Metab Date: 1998-01 Impact factor: 5.958
Authors: Remberto C Paulo; Mihaela Cosma; Cacia Soares-Welch; Joy N Bailey; Kristi L Mielke; John M Miles; Cyril Y Bowers; Johannes D Veldhuis Journal: J Clin Endocrinol Metab Date: 2007-12-11 Impact factor: 5.958
Authors: Geber Pena; Christina Michalski; Robert J Donnelly; Yong Qin; Ziad C Sifri; Anne C Mosenthal; David H Livingston; Zoltan Spolarics Journal: Shock Date: 2017-04 Impact factor: 3.454
Authors: Animesh N Sharma; Paul Aoun; Jean R Wigham; Suanne M Weist; Johannes D Veldhuis Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-02-26 Impact factor: 3.619